Rita E. Numerof Ph.D.

Rita E. Numerof Ph.D.

Rita E. Numerof Ph.D.'s picture
Rita E. Numerof, Ph.D. is President of Numerof & Associates, Inc. Numerof is a strategy development and implementation firm with more than 25 years’ experience helping major pharmaceutical, device, diagnostic, payer and delivery organizations create and deliver value across healthcare. Experts in business model transformation, Numerof specializes in redesigning commercial models, developing economic and clinical value propositions, and crafting market access strategies for the pharmaceutical industry worldwide. For more information, visit our website at www.nai-consulting.com

Latest posts from Rita:

Column

Transparency around Value to...

Dec 28, 2016

Rising drug prices have been hotly debated this year with a greater push for...

Column

Adapting the Commercial Process to...

Oct 14, 2016

3 ideas pharma should consider in modifying their commercial approach.

Column

Planning for Success in an IDN...

Mar 4, 2016

Manufacturers can be a valuable partner helping IDNs create a more compelling...

Column

Preparing for Population Health...

Oct 15, 2015

How can pharma prepare for this new value-driven environment?

Column

Reference Pricing on the Horizon

Sep 9, 2015

Reference pricing is not widely used in the US, but it has been on the radar...

Column

Considerations for Risk Sharing...

Jun 23, 2015

There are several important questions that should be asked before entering into...

Column

Key Considerations for Successful...

May 14, 2015

Why this trend has surfaced and key considerations for pharmaceutical companies...

Column

Market Segmentation in the New...

Apr 16, 2015

In order to remain competitive, pharmaceutical companies must shift their focus...

Column

Selling to IDNs: Strategies for...

Feb 25, 2015

Changes in healthcare delivery are rapidly undermining traditional...

Column

IDNs - What Pharma Needs to Know

Jan 19, 2015

One of the most rapidly emerging trends in healthcare is the formation of...

Pages